Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-11-18
1993-06-22
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 13, 514 21, 530324, 530325, 530326, 530350, 530842, A61K 3702, C07K 710
Patent
active
052216640
ABSTRACT:
A composition comprising a biologically active amphiphilic ion channel-forming peptide or ion channel forming protein and a toxic cation, such as a silver cation. Such compositions may be employed as pharmaceuticals, particularly for the treatment and prevention of eye infections.
REFERENCES:
patent: 4507230 (1985-03-01), Tam et al.
patent: 4962277 (1990-10-01), Cuervo et al.
Gibson, et al., "Novel Peptide Fragments Originating from PGLa and the Caerulein and Xenopsin Precursors" from Xenopus laevis, J. Biol. Chem., vol. 261, No. 12 (Apr. 25, 1986).
Giovannini, et al. "Biosynthesis and Degradation of Peptides Derived from Xenopus laevis Prohormones," Biochem J., vol. 243, pp. 113-120 (1987).
Christensen, et al., Proc. Nat. Acad. Sci., vol. 85, pp. 5072-5076 (Jul. 1988).
Berkowitz Barry
Jacob Leonard
Lee Lester L.
Lillie Raymond J.
Magainin Pharmaaceuticals Inc.
Olstein Elliot M.
Salata Carol
LandOfFree
Composition and treatment with biologically active peptides and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and treatment with biologically active peptides and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and treatment with biologically active peptides and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441068